Delivery Order SPE2DB22D3501-SPE2DB25FWP11
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $4,504.40 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizures, representing specialized...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used to treat acute seizure clusters in patients with epilepsy, representing a specialized pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,226.52 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation on July 18, 2025. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized pharmaceutical product critical to military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with performance in Conshohocken, Pennsylvania and completion by July 23, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing typical of DLA pharmaceutical procurement. Valtoco is a rescue medication indicated for acute repetitive seizure episodes, reflecting the broad therapeutic scope of...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.44 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed price contract, awarded on July 25, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $6,847.08 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania facility. Valtoco is a seizure rescue medication indicated for acute repetitive seizures, representing part of the company's broader pharmaceutical supply portfolio...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,309.22 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 28, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 26, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWP11Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,301.07 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, effective July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute seizure management, reflecting the pharmaceutical supply needs of military and federal healthcare systems supported through DLA's medical supply chain. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical supplies to support Defense Health Agency and other federal healthcare programs. The company's extensive experience fulfilling competitive federal contracts demonstrates its capability to meet specialized pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/24/25 |